chookman
Have a look at their presentation on their website and comparison to ISN's timeline, business model and product - very exciting.
We all agree burette is a slow process, but already in Taiwan and soon to be Brazil - majors testing it in US and EUR is a huge sign. Just need to start hurting their bottom line for them to make a move there.
PeriCoach entirely different - all a marketing play just like ISN's device. They got that to a $180M market cap on no FDA or revenue.
Exciting times here, last time WiseOwl covered them it went to 3.4c and only had 1 product - we now have 2 and one in the MHealth market which is massive
- Forums
- ASX - By Stock
- ALT
- wiseowl research - 7.6c buy recommendation
wiseowl research - 7.6c buy recommendation, page-3
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online